Neuromyelitis optica: clinical features, immunopathogenesis and treatment
The term ‘neuromyelitis optica’ (‘Devic's syndrome’, NMO) refers to a syndrome characterized by optic neuritis and myelitis. In recent years, the condition has raised enormous interest among scientists and clinical neurologists, fuelled by the detection of a specific serum immunoglobulin (Ig)G...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 January 2014
|
| In: |
Clinical & experimental immunology
Year: 2014, Volume: 176, Issue: 2, Pages: 149-164 |
| ISSN: | 1365-2249 |
| DOI: | 10.1111/cei.12271 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/cei.12271 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/cei.12271 
|
| Author Notes: | S. Jarius, B. Wildemann and F. Paul |
| Summary: | The term ‘neuromyelitis optica’ (‘Devic's syndrome’, NMO) refers to a syndrome characterized by optic neuritis and myelitis. In recent years, the condition has raised enormous interest among scientists and clinical neurologists, fuelled by the detection of a specific serum immunoglobulin (Ig)G reactivity (NMO-IgG) in up to 80% of patients with NMO. These autoantibodies were later shown to target aquaporin-4 (AQP4), the most abundant water channel in the central nervous system (CNS). Here we give an up-to-date overview of the clinical and paraclinical features, immunopathogenesis and treatment of NMO. We discuss the widening clinical spectrum of AQP4-related autoimmunity, the role of magnetic resonance imaging (MRI) and new diagnostic means such as optical coherence tomography in the diagnosis of NMO, the role of NMO-IgG, T cells and granulocytes in the pathophysiology of NMO, and outline prospects for new and emerging therapies for this rare, but often devastating condition. |
|---|---|
| Item Description: | Gesehen am 10.09.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1365-2249 |
| DOI: | 10.1111/cei.12271 |